Immunochemical and Biological Reactivity of Human Anti-Lipopolysaccharide IgG Obtained by Screening of Blood Donors
- 1 March 1989
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 29 (3) , 309-316
- https://doi.org/10.1111/j.1365-3083.1989.tb01129.x
Abstract
An anti-lipopolysaccharide (LPS) preparation for the intravenous treatment of septic endotoxic shock was prepared by purifying immunoglobulin G (IgG) from pooled serum from Danish blood donors. The sera were selected by the use of an enzyme-linked immunosorbent assay (ELISA) to screen blood donors for high concentrations of antibodies to a mixture of LPS from 11 different Gram-negative bacteria. ELISA was also used for indirect quantification of IgG antibodies to lipid A, and to rough LPS from Escherichia coli Ra and Salmonella minnesota R60 (Ra). The concentration of human antibodies to the LPS mixture correlated with the concentration of antibodies to the E. coli and S. minnesota rough LPS and to lipid A. The specificity of sera with high concentrations of anti-LPS IgG was investigated by immunoblotting. Sera from individual donors reacted with LPS from different bacteria and recognized different sites on the LPS molecules. The range of specificities to different LPS was increased by the pooling of selected sera. The IgG fraction from the high titre donor pool neutralized biological activities of LPS such as activation of the Limulus amoebocyte lysate reaction and induction of tumor necrosis factor secretion from human monocytes.This publication has 29 references indexed in Scilit:
- Detection of Tumour Necrosis Factor from Lipopolysaccharide‐Stimulated Human Mononuclear Cells by Enzyme‐Linked Immunosorbent Assay and Cytotoxicity BioassayScandinavian Journal of Immunology, 1988
- Elisa for Human IgG and IpM Anti-Lipopolysaccharide Antibodies with Indirect StandardizationJournal of Immunoassay, 1987
- Controversies in the Use of Passive Immunotherapy for Bacterial Infections in the Critically Ill PatientClinical Infectious Diseases, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Antibodies to Lipid A: Occurrence in HumansClinical Infectious Diseases, 1984
- BLOOD DONORS AS SOURCE OF ANTI-GRAM-NEGATIVE ANTIBODIESThe Lancet, 1983
- Immunization with Rough Mutants of Salmonella minnesota. IV. Protection by Antisera to O and Rough Antigens Against EndotoxinThe Journal of Infectious Diseases, 1983
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Preparation and Properties of Antisera against the Lipid‐A component of Bacterial LipopolysaccharidesEuropean Journal of Biochemistry, 1971
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970